Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.
Trial details
- Registry ID
- NCT05463679
- Drugs studied
- Enzastaurin
TrialRedline tracks 1 clinical trial sponsored by Aytu BioPharma, Inc.: 1 Phase 3.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.NCT05463679 | Enzastaurin | Suspended | 2025-06Estimated |
Names as written in the registry records.